KSG Investigates Janssen’s Dangerous Type 2 Diabetes Drug, Invokana: Amputation Risk, Heart Attack, Kidney Failure, Ketoacidosis, UTI, Etc.

KSG is investigating claims for a lawsuit against Janssen Pharmaceuticals, Inc, a subsidiary of Johnson & Johnson Co. for its dangerous type 2 diabetes Drug, Invokana (canagliflozin) , a SGLT2 inhibitor antidiabetic. This drug’s primary purpose is to treat Type 2 Diabetes which hampers the body’s ability to process glucose for energy production. Unlike other… Read More